DRUGS AFFECTING TRIGLYCERIDES

被引：10
作者：
CAPURSO, A
机构：
[1] Institute of Clinical Medicine, University of Bari Medical School, Bari
来源：
CARDIOLOGY | 1991年 / 78卷 / 03期
关键词：
TRIGLYCERIDES; DRUGS; BECLOBRATE;
D O I：
10.1159/000174788
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nicotinic acid and clofibrate derivatives are the main triglyceride-metabolism-affecting drugs. Nicotinic acid and its derivatives block adipose tissue lipolysis thus reducing the FFA flux of free fatty acids to the liver and the synthesis of very-low-density lipoproteins (VLDL). VLDL removal rate is also enhanced. Disturbing side effects (mostly flushing) limit the use of this compound. Clofibrate and its derivatives decrease the synthesis of VLDL and increase their catabolism. Lipoprotein lipase activity as well as VLDL fractional catabolic rate are increased by fibrates. Triglyceride synthesis is also reduced.
引用
收藏
页码：218 / 225
页数：8
相关论文
共 38 条
[1]   INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].
ALTSCHUL, R ;
HOFFER, A ;
STEPHEN, JD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559
[2]  
ALVORSEN O, 1983, BIOCHEM PHARMACOL, V32, P1126
[3]  
ANDERSSON RGG, 1977, ACTA PHARMACOL TOX, V41, P1
[4]   BECLOBRINIC ACID - A NEW HYPOLIPIDEMIC AGENT - INHIBITS INVITRO HUMAN PLATELET ACTIVATION BY BLOCKING PROSTAGLANDIN SYNTHESIS [J].
ANWER, K ;
GABIS, J ;
ROMSTEDT, K ;
GOJER, C ;
HUZOORAKBAR .
LIFE SCIENCES, 1985, 37 (01) :63-70
[5]  
BOBERG J, 1971, METABOLIC EFFECTS NI, P465
[6]  
BROWN MS, 1983, J CLIN INVEST, V72, P747
[7]  
BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375
[8]  
Carlson L A, 1979, Prog Biochem Pharmacol, V15, P238
[9]   EFFECT OF CHLOROPHENOXYISOBUTYRIC ACID (CPIB) ON FAT-MOBILIZING LIPOLYSIS AND CYCLIC-AMP LEVELS IN RAT EPIDIDYMAL FAT [J].
CARLSON, LA ;
WALLDIUS, G ;
BUTCHER, RW .
ATHEROSCLEROSIS, 1972, 16 (03) :349-357
[10]  
CHAZAN JB, 1984, TREATMENT HYPERLIPOP, P171
1234